Axis Bank Ltd vs Prism Medico & Pharmacy Ltd

A side-by-side comparison of Axis Bank Ltd (AXISBANK) and Prism Medico & Pharmacy Ltd (PRISMMEDI) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Axis Bank Ltd leads AXISBANK vs PRISMMEDI on 8 of 14 metrics (4 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

14.82
P/E ratio
120.40
1.97
P/B ratio
1.64
0.08%
Dividend yield
0.00%
₹84.89
EPS
₹0.24

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

13.10%
Return on equity
0.31%
6.24%
Return on capital
0.08%
0.00%
EBITDA margin
0.00%
0.00%
Net margin
0.00%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
34.47%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.08L Cr
Market cap
₹41 Cr
₹0 Cr
Revenue
₹28.14L Cr
₹26,548 Cr
Net profit
₹-0 Cr
0.00
Debt / equity
0.17
Axis Bank Ltd
  • + ["Company has delivered good profit growth of 29.6% CAGR over last 5 years", "Company's working capital requirements have reduced from 73.7 days to 43.2 days"]
  • ["Company has low interest coverage ratio.", "Promoter holding is low: 7.87%", "Contingent liabilities of Rs.31,22,124 Cr.", "Company might be capitalizing the interest cost", "Earnings include an other income of Rs.29,292 Cr."]
Prism Medico & Pharmacy Ltd
  • + ["Company is almost debt free.", "Stock is trading at 1.09 times its book value"]
  • ["Promoter holding is low: 30.2%", "Company has a low return on equity of 0.55% over last 3 years.", "Company has high debtors of 588 days."]
Axis Bank Ltd full analysis Prism Medico & Pharmacy Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.